Effectiveness of Visceral Manual Therapy in Bruxist Patients
Launched by UNIVERSITY OF SEVILLE · Mar 1, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective a treatment called visceral manual therapy is for patients who grind their teeth (bruxism) and also experience gastroesophageal reflux (a condition where stomach acid flows back into the esophagus, causing discomfort). The researchers want to find out if this therapy can improve symptoms in these patients.
To participate, you must be over 18 years old and have a diagnosis of bruxism from a dentist, as well as a score higher than 8 on a specific reflux questionnaire. If you join the study, you will be randomly placed in one of two groups: one will receive actual visceral manual therapy, while the other will receive a placebo treatment that feels similar but doesn’t have any real effect. You will need to visit the clinic three times, with treatments occurring one week apart, and your symptoms will be assessed before and after the treatments, as well as one month later. This study is currently recruiting participants, and it’s important to note that there are several health conditions that would exclude someone from taking part, such as recent surgeries, certain diseases, or if you’re pregnant.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects with bruxism diagnosed and referred by a dentist
- • Age: older than 18 years-old.
- Exclusion Criteria:
- • Recent craniofacial, mandibular or cervical trauma or fracture.
- • Temporomandibular joint surgery.
- • Acute pain due to other components of the masticatory system (caries, inflammation of the dental root).
- • Abdominal surgery.
- • Gastric ulcers.
- • Gastritis.
- • Previous or current gastric neoplasm.
- • Neurological or systemic diseases.
- • Pregnant, including the period of breastfeeding.
- • Patients receiving chemotherapy or radiotherapy.
- • Cognitive, psychosomatic or psychiatric illnesses that may affect the data obtained.
- • Basic systemic disease of rheumatic origin (for example, arthritis, osteoarthritis, gout and psoriasis).
- • Cerebrovascular and brain diseases.
- • Arrhythmia and other cardiac problems.
- • Implanted electronic devices.
- • Drug or alcohol abuse, analgesic or sedative therapy, and use of medications that affect the central nervous system (for example, antidepressants, anxiolytics, and anticonvulsants).
- • Patients who have previous experience with manual treatment of the diaphragm
About University Of Seville
The University of Seville is a prestigious academic institution dedicated to advancing knowledge through innovative research and exceptional education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at enhancing patient care and medical outcomes. Its commitment to rigorous scientific inquiry and ethical standards positions it as a leading sponsor in the field of clinical research, fostering partnerships with healthcare professionals and institutions to drive advancements in medical science and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seville, , Spain
Patients applied
Trial Officials
Lourdes M Fernández Seguín, PhD
Principal Investigator
University of Seville
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials